‘A trove of rebound opportunities': Strategists turn bullish on biotech and more, picking top stocks [CNBC]
Biomea Fusion, Inc. (BMEA)
Company Research
Source: CNBC
tech as areas to watch. “Emerging from a poor capital raising environment in '22-23, where early-stage biotech companies grappled to fund their Research and Development efforts amid rising interest rates, the battered sector finally is seeing a revival in Mergers and Acquisition deals as the new year begins,” Citi Global Wealth Investments said in a Jan. 14 note. There's already been about $9.6 million worth of transactions so far in January, the bank noted. As a sector, health care underperformed the broader market last year, with the iShares U.S. Healthcare ETF gaining only around 2% for 2023. But now, Citi believes that “astute investors may find themselves with a trove of rebound opportunities.” It urged investors to reflect on the “inherent resilience” of health care over the long term, noting that the sector recorded positive earnings growth over the three recent global earnings recessions. “As macro tides shift, we see health care as an unstoppable trend beneficiary, with growt
Show less
Read more
Impact Snapshot
Event Time:
BMEA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMEA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMEA alerts
High impacting Biomea Fusion, Inc. news events
Weekly update
A roundup of the hottest topics
BMEA
News
- Biomea Fusion, Inc. (NASDAQ: BMEA) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $70.00 price target on the stock.MarketBeat
- Biomea Fusion, Inc. (NASDAQ: BMEA) had its "neutral" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $14.00 price target on the stock, down previously from $51.00.MarketBeat
- Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- Biomea Fusion, Inc. (NASDAQ: BMEA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.MarketBeat
- Biomea Fusion, Inc. (NASDAQ: BMEA) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $55.00 price target on the stock.MarketBeat
BMEA
Earnings
- 4/1/24 - Miss
BMEA
Sec Filings
- 4/26/24 - Form ARS
- 4/26/24 - Form DEF
- 4/10/24 - Form SC
- BMEA's page on the SEC website